Template

Show index

Template CDA Precondition 2005‑09‑07

Id2.16.840.1.113883.10.12.329
ref
ad1bbr-
Effective Date2005‑09‑07
Statusactive ActiveVersion Label
NameCDAPreconditionDisplay NameCDA Precondition
DescriptionTemplate CDA Precondition (prototype, directly derived from POCD_RM000040 MIF)
ClassificationCDA Entry Level Template
Open/ClosedOpen (other than defined elements are allowed)
Used by / Uses
Used by 6 transactions and 178 templates, Uses 0 templates
Used by as NameVersion
2.16.840.1.113883.3.1937.99.61.26.4.7Transactiondraft Base Document2016‑10‑08 19:37:05
2.16.840.1.113883.2.9.10.1.10.4.3Transactiondraft (it-IT) Crea Act2018‑07‑20 17:01:17
2.16.840.1.113883.3.1937.777.15.4.2Transactiondraft Create Medication Order2017‑05‑10
2.16.756.5.30.1.127.77.2.4.2Transactiondraft CDA-CH - StructuredBody (2020)2017‑11‑10 09:35:28
2.16.840.1.113883.2.6.60.6.4.2Transactiondraft CDA Document Anatomic Pathology Structured Report 2015 (2.0)2015‑10‑23 10:32:36
2.16.756.5.30.1.127.77.2.4.4Transactioncancelled CDA-CH - StructuredBody Enhanced (2018)2018‑02‑12 17:54:58
1.2.40.0.34.6.0.11.3.139linkactive EXNDS Preis Arzneimittel (1.0.0+20210310)2020‑10‑06 15:47:15
1.2.208.184.2.10.9linkdraft CDA ClinicalDocument (with StructuredBody)2023‑07‑04 08:28:40
1.2.208.184.10.1.10linkcancelled DK ClinicalDocument (with StructuredBody)2021‑08‑30 14:09:05
1.2.208.184.10.1.13linkdraft DK Medcom ClinicalDocument (with StructuredBody) (1.5)2021‑08‑30 14:26:22
1.2.208.184.10.1.44linkdraft DK Medcom ClinicalDocument (with StructuredBody) (1.5)2023‑07‑04 13:52:36
1.2.208.184.10.15linkdraft PDC DK CDA Section2019‑12‑14 17:24:10
1.2.208.184.10.32linkdraft APD CDA Clinical Statement2020‑06‑21 16:54:06
1.2.208.184.10.33Containmentdraft APD CDA Observation2020‑06‑21 17:05:15
1.2.208.184.11.1.1linkcancelled DK CDA ClinicalDocument (with StructuredBody)2021‑08‑13 10:06:00
1.2.208.184.14.11.2Containmentdraft Appointment CDA Encounter2019‑12‑15 23:32:24
1.2.208.184.15.1.10.20.1linkdraft Health Concern Section2018‑11‑28 20:54:17
1.2.208.184.15.1.10.20.2linkdraft Goal Section2018‑11‑28 20:58:20
1.2.208.184.15.1.10.20.3linkdraft Interventions Section2018‑11‑28 21:00:20
1.2.208.184.15.1.10.20.4linkdraft Outcomes Section2018‑11‑28 21:01:23
1.2.208.184.16.1.10.20.1.20Containmentdraft PDC DK Language CDA Observation2019‑12‑22 11:41:45
1.2.208.184.16.1.10.20.1.21Containmentdraft PDC DK Temporary Address CDA Observation2019‑12‑22 11:43:31
1.2.208.184.16.1.10.20.1.22Containmentdraft PDC DK Dentist CDA Observation2019‑12‑22 11:45:33
1.2.208.184.16.1.10.20.1.23Containmentdraft PDC DK Custody CDA Observation2019‑12‑22 11:22:08
1.2.208.184.16.1.10.20.1.24Containmentdraft PDC DK Contact CDA Observation2019‑12‑22 11:46:44
1.2.208.184.16.1.10.20.1.25Containmentdraft PDC DK Relative CDA Observation2019‑12‑22 11:48:03
1.2.208.184.16.1.10.20.1.26Containmentdraft PDC DK Citizen CDA Observation2019‑12‑22 11:29:00
1.2.208.184.16.1.10.20.1.27Containmentdraft PDC DK Coverage CDA Observation2019‑12‑22 11:33:55
1.2.208.184.16.1.10.20.1.28Containmentdraft PDC DK Organ CDA Observation2019‑12‑22 11:35:31
1.2.208.184.16.1.10.20.1.29Containmentdraft PDC DK Treatment Will CDA Observation2019‑12‑22 11:38:15
1.2.208.184.16.1.10.20.1.30Containmentdraft PDC DK Living Will CDA Observation2019‑12‑22 11:39:56
1.2.276.0.76.3.1.85.200.77.10.2linkdraft Diagnose2016‑01‑29 12:27:26
1.2.276.0.76.3.1.85.200.77.10.3linkdraft Therapie2016‑01‑29 12:28:19
1.2.276.0.76.3.1.85.200.77.10.4linkdraft Wundbeurteilung2016‑01‑29 12:33:12
1.2.276.0.76.3.1.85.200.77.10.7linkdraft psychosoziale Faktoren2016‑02‑04 15:14:55
1.2.276.0.76.3.1.85.200.77.10.8linkdraft individuelle Risikofaktoren2016‑02‑04 15:24:45
1.2.276.0.76.3.1.85.200.77.10.9linkdraft Risikoasssessment2016‑02‑04 15:28:02
1.2.276.0.76.3.1.85.200.77.10.10linkdraft HygieneAssessment2016‑02‑04 15:30:47
1.2.276.0.76.3.1.85.200.77.10.11linkdraft Hautassessment2016‑02‑04 15:33:52
1.2.276.0.76.3.1.85.200.77.10.12linkdraft Details über geheilte Wunden2016‑02‑04 15:37:09
1.2.276.0.76.3.1.85.200.77.10.13linkdraft gesundheitsrelevantes Patientenverhalten2016‑02‑04 15:45:40
1.2.276.0.76.3.1.85.200.77.10.14linkdraft körperliche Beeinträchtigungen2016‑02‑04 15:48:19
1.2.276.0.76.3.1.85.200.77.10.15linkdraft psychosoziale Beeinträchtigungen2016‑02‑04 15:51:13
1.2.276.0.76.3.1.85.200.77.10.17linkdraft relevante med. Daten2016‑02‑04 16:07:34
1.2.276.0.76.3.1.85.200.77.10.18linkdraft Behandlungsziele2016‑02‑04 16:17:24
1.2.276.0.76.3.1.85.200.77.10.19linkdraft Behandlungsplan2016‑02‑04 16:22:01
1.2.276.0.76.3.1.85.200.77.10.20linkdraft benötigte Ausrüstung2016‑02‑04 16:27:22
1.2.276.0.76.3.1.85.200.77.10.21linkdraft Heilungs- und Therapieverlauf2016‑02‑04 16:32:28
1.2.276.0.76.3.1.85.200.77.10.22linkdraft Schmerzmanagement2016‑02‑04 16:36:00
1.2.276.0.76.3.1.85.200.77.10.23linkdraft Hygienemaßnahmen2016‑02‑04 16:40:10
1.2.276.0.76.3.1.85.200.77.10.24linkdraft Wundrandschutz2016‑02‑04 16:43:46
1.2.276.0.76.3.1.85.200.77.10.25linkdraft Kausaltherapie2016‑02‑04 16:46:11
1.2.276.0.76.3.1.85.200.77.10.26linkdraft Patientenedukation2016‑02‑04 16:49:29
1.2.276.0.76.3.1.85.200.77.10.27linkdraft bisherige Ergebnisse2016‑02‑04 16:54:50
1.3.6.1.4.1.19376.1.3.1.6linkdraft IHE Laboratory Observation (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015)2016‑06‑24 13:58:31
1.3.6.1.4.1.19376.1.3.3.2.2linkdraft Laboratory Report Item Section (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015)2016‑06‑24 12:44:54
1.3.6.1.4.1.19376.1.3.10.3.1linkdraft Additional Specified Observation Section (2.0)2016‑11‑13 14:28:08
1.3.6.1.4.1.19376.1.3.10.4.2linkdraft UICC/AJCC TNM Staging and Grading Observation (2.0)2014‑05‑13 15:45:13
1.3.6.1.4.1.19376.1.3.10.4.3linkdraft ICD-O-3 Typing and Grading Observation (2.0)2015‑11‑29 17:03:18
1.3.6.1.4.1.19376.1.3.10.4.4Containmentcancelled CDA Supply Container APSR2 (1.0)2016‑07‑29
1.3.6.1.4.1.19376.1.3.10.4.4Containmentcancelled Assessment Scales for Scoring Systems APSR2 (1.9)2016‑10‑06 12:36:29
1.3.6.1.4.1.19376.1.3.10.4.4linkdraft Assessment Scales Observation for Scoring Systems (2.0)2016‑10‑06 13:12:00
1.3.6.1.4.1.19376.1.3.10.9.33linkdraft TNM Serum tumor markers (2.0)2015‑11‑06 14:28:44
1.3.6.1.4.1.19376.1.3.10.9.42Containmentdraft Assessment Scoring System APSR 2.0 (2.0)2016‑10‑10 11:33:36
1.3.6.1.4.1.19376.1.8.1.1.1linkdraft Anatomic Pathology Structured Report Content Module (2.0)2014‑05‑13 11:57:57
1.3.6.1.4.1.19376.1.8.1.2.1linkdraft Clinical Information Section (2.0)2014‑05‑13 14:38:08
1.3.6.1.4.1.19376.1.8.1.2.2linkdraft Intraoperative Observation Section (2.0)2014‑05‑13 19:29:16
1.3.6.1.4.1.19376.1.8.1.2.3linkdraft Macroscopic Observation Section (2.0)2014‑05‑13 11:57:09
1.3.6.1.4.1.19376.1.8.1.2.4linkdraft Microscopic Observation Section (2.0)2014‑05‑13 14:25:17
1.3.6.1.4.1.19376.1.8.1.2.5linkdraft Diagnostic Conclusion Section (2.0)2014‑05‑13 19:31:26
1.3.6.1.4.1.19376.1.8.1.3.6linkdraft Problem Organizer (2.0)2015‑08‑13 10:24:55
1.3.6.1.4.1.19376.1.8.1.4.9linkdraft AP Observation Entry (2.0)2014‑05‑14 17:09:54
2.16.756.5.30.1.1.10.1.9linkactive CDA-CH v2.1 - structuredBody (2020)2019‑10‑17 15:22:41
2.16.756.5.30.1.1.10.1.14linkactive CDA-CH v2.0 - structuredBody enhanced (2018)2018‑04‑18
2.16.840.1.113883.2.6.60.2.10.3001linkdraft NFD Section Allergien, Unverträglichkeiten2014‑06‑29 13:35:11
2.16.840.1.113883.2.6.60.2.10.3005linkdraft NFD Section Schwangerschaft2014‑07‑07 14:19:33
2.16.840.1.113883.2.6.60.2.10.3006linkdraft NFD Section Risiken Ressourcen2014‑07‑07 14:32:47
2.16.840.1.113883.2.6.60.2.10.4003Containmentdraft NFD Entry Concern2014‑07‑02 15:10:03
2.16.840.1.113883.2.6.60.2.10.4004Containmentretired NFD Entry Problem2014‑07‑02 15:11:28
2.16.840.1.113883.2.6.60.2.10.4005linkdraft NFD Entry Medikation Verordnung2014‑07‑02 14:54:43
2.16.840.1.113883.2.6.60.3.10.1Containmentretired CDA SubstanceAdministration2016‑04‑22 10:50:09
2.16.840.1.113883.2.6.60.6.10.45Containmentdraft Elston-Ellis-Grading2016‑05‑24 21:55:39
2.16.840.1.113883.2.6.60.6.10.47Containmentdraft Elston-Ellis Nuclear Pleomorphism2016‑05‑25 08:13:04
2.16.840.1.113883.2.6.60.6.10.48Containmentdraft Elston-Ellis Mitotic Count Score2016‑05‑25 11:18:02
2.16.840.1.113883.2.9.10.1.6.43Containmentdraft CDA Observation2017‑05‑04 18:42:02
2.16.840.1.113883.2.9.10.1.10.3linkdraft Act Esenzione2018‑05‑21 15:56:46
2.16.840.1.113883.2.9.77.1.10.900238Containmentdraft CDA Observation2016‑05‑28 22:16:29
2.16.840.1.113883.2.51.10.38linkcancelled XeH Care Provision Act2021‑10‑18 16:17:01
2.16.840.1.113883.3.51.60.2.0linkdraft BC CDA Clinical Document Header2016‑04‑03 18:54:58
2.16.840.1.113883.3.51.60.3.3linkdraft BC CDA StructuredBody2016‑04‑04 16:51:10
2.16.840.1.113883.3.1818.10.1.2.1linkrejected BC CDA ClinicalDocumentGenericEpisodic2016‑11‑28 15:06:29
2.16.840.1.113883.3.1818.10.1.3.1linkrejected BC CDA ClinicalDocumentPatientTransfer2017‑03‑30 10:51:43
2.16.840.1.113883.3.1818.10.3.3linkdraft BC Allergy Intolerance Observation Act2017‑04‑02 06:50:15
2.16.840.1.113883.3.1818.10.3.3linkdraft BC Allergy Intolerance Observation Act2017‑04‑02 08:00:43
2.16.840.1.113883.3.1818.10.3.3linkdraft BC Allergy Intolerance Observation Act2017‑04‑02 08:08:32
2.16.840.1.113883.3.1818.10.3.9linkdraft BC Encounter Event2017‑04‑02 22:14:30
2.16.840.1.113883.3.1818.10.4.7Containmentdraft BC Medication Dispense Event2017‑04‑01 05:18:24
2.16.840.1.113883.3.1818.10.4.20linkdraft BC Medication Prescription Event2017‑04‑01 06:19:37
2.16.840.1.113883.3.1818.10.4.24Containmentdraft BC Reason Observation2017‑04‑01 05:57:31
2.16.840.1.113883.3.1818.10.4.30Containmentdraft BC Severity Observation2017‑04‑01 22:54:28
2.16.840.1.113883.3.1818.10.4.37Containmentdraft BC Order Indicator2017‑04‑01 05:39:26
2.16.840.1.113883.3.1818.10.4.38linkdraft BC Record ID Link2017‑04‑01 05:48:33
2.16.840.1.113883.3.1937.99.61.5.10.900216linkdraft CDA Observation2013‑12‑04 10:55:24
2.16.840.1.113883.3.1937.99.61.5.10.900239linkdraft eLab_Specimen Received_2014‑01‑14 14:12:16
2.16.840.1.113883.3.1937.99.61.5.10.900240linkdraft eLab_Specimen Received_2014‑01‑14 14:12:39
2.16.840.1.113883.3.1937.99.61.5.10.900241linkdraft eLab_Specimen Received_2014‑01‑14 14:13:27
2.16.840.1.113883.3.1937.99.61.5.10.900242linkdraft eLab_Specimen Received_2014‑01‑14 14:13:28
2.16.840.1.113883.3.1937.99.61.5.10.900243Containmentdraft eLab_Specimen Received_2014‑01‑14 14:13:28
2.16.840.1.113883.3.1937.99.61.5.10.900244linkdraft eLab_Specimen Received_2014‑01‑14 14:13:29
2.16.840.1.113883.3.1937.99.61.5.10.900245Containmentdraft eLab_Specimen Received_2014‑01‑14 14:13:29
2.16.840.1.113883.3.1937.99.61.5.10.900246linkdraft eLab_Specimen Received_2014‑01‑14 14:13:29
2.16.840.1.113883.3.1937.99.61.5.10.900247linkdraft eLab_Specimen Received_2014‑01‑14 14:13:30
2.16.840.1.113883.3.1937.99.61.5.10.900265linkdraft CDA Organizer2014‑01‑14 14:17:08
2.16.840.1.113883.3.1937.99.61.5.10.900276linkdraft TNM Observation2014‑05‑13 15:45:13
2.16.840.1.113883.3.1937.99.61.5.10.900280Containmentdraft APSR2 AP Observation Entry2014‑05‑14 17:09:54
2.16.840.1.113883.3.1937.99.61.5.10.900290linkdraft ADT-Tod2014‑12‑02 09:05:37
2.16.840.1.113883.3.1937.99.61.5.10.900293linkdraft ADT Tod2014‑12‑02 11:02:38
2.16.840.1.113883.3.1937.99.61.5.10.900296linkdraft TNM M-Observation2014‑12‑02 16:32:30
2.16.840.1.113883.3.1937.99.61.5.10.900304linkdraft APSR2 Specimen Organizer2014‑12‑22 17:58:40
2.16.840.1.113883.3.1937.99.61.5.10.900311linkdraft CDA SubstanceAdministration2018‑08‑02 12:16:53
2.16.840.1.113883.3.1937.99.61.5.10.900312Containmentdraft CDA SubstanceAdministration2018‑08‑02 12:18:33
2.16.840.1.113883.3.1937.99.61.19.10.24linkdraft CDA Observation12017‑08‑10 15:15:49
2.16.840.1.113883.3.1937.99.61.19.10.71linkdraft Ambulanzbefund2019‑05‑10 08:58:00
2.16.840.1.113883.3.1937.99.61.19.10.78linkactive TEST_AKL_Ambulanzbefund (2020)2020‑02‑05 15:44:24
2.16.840.1.113883.3.1937.99.61.19.10.78linkdraft TEST_AKL_Ambulanzbefund (2020.1)2020‑11‑25 10:42:33
2.16.840.1.113883.3.1937.99.61.21.10.75linkdraft Radiology Comparison Study - Observation2020‑08‑11 20:29:30
2.16.840.1.113883.3.1937.99.61.27.10.3linkdraft tsc_test_CDASection2016‑05‑27 11:53:53
2.16.840.1.113883.3.1937.99.61.27.10.4linkdraft Laboratory Specialty Text and Entry (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015)2016‑06‑24 12:40:20
2.16.840.1.113883.3.1937.99.61.27.10.11linkdraft CDA Observation2018‑11‑13 14:00:31
2.16.840.1.113883.3.1937.99.61.27.10.12linkdraft JBl_CDA Observation (JBL-V1)2018‑11‑13 14:14:08
2.16.840.1.113883.3.1937.99.61.27.10.13linkdraft NewTemplate (V0)2018‑11‑13 14:14:16
2.16.840.1.113883.3.1937.99.61.27.10.14linkdraft JBl_CDA Observation (JBL-V1)2018‑11‑13 14:14:49
2.16.840.1.113883.3.1937.99.61.27.10.15linkdraft PGRNewTemplateTest (V0)2018‑11‑13 14:17:21
2.16.840.1.113883.3.1937.99.61.27.10.16Containmentdraft NewTemplate (V0)2018‑11‑13 14:17:38
2.16.840.1.113883.3.1937.99.61.27.10.17linkdraft CDA ClinicalDocument (with StructuredBody)2019‑08‑22 09:46:40
2.16.840.1.113883.3.1937.99.61.27.10.18linkdraft CDA ClinicalDocument (with StructuredBody)2019‑08‑22 09:46:48
2.16.840.1.113883.3.1937.99.61.27.10.19Containmentdraft FLM_SupplyOneRelationShipSubstanceAdministration (2019)2019‑08‑29 14:54:39
2.16.840.1.113883.3.1937.99.61.27.10.20Containmentdraft FLM_SubstanceAdministration2019‑08‑29 15:03:30
2.16.840.1.113883.3.1937.99.61.27.10.21linkdraft FLM_Supply2019‑08‑29 15:51:42
2.16.840.1.113883.3.1937.99.61.27.10.22linkdraft FLM_SubstanceAdministration22019‑09‑01 21:32:53
2.16.840.1.113883.3.1937.99.61.27.10.23Containmentdraft FLM_SupplyTwoRelationShipToSubstanceAdministration2019‑09‑01 21:33:57
2.16.840.1.113883.3.1937.99.61.28.10.4linkdraft CDA Nivel 1 (1)2017‑04‑22 23:33:51
2.16.840.1.113883.3.1937.99.61.30.10.64linkdraft Prescrizione specialistica (with StructuredBody) (1.0)2022‑06‑13 15:50:01
2.16.840.1.113883.3.1937.99.61.30.10.65linkdraft Prescrizione farmaceutica (with StructuredBody) (1.0)2022‑06‑13 17:14:33
2.16.840.1.113883.3.1937.99.61.31.10.1.2linkdraft My Section2014‑02‑08 16:16:07
2.16.840.1.113883.3.1937.99.61.45.10.5linkrejected CDA Section t2018‑04‑16 11:44:27
2.16.840.1.113883.3.1937.99.61.45.10.6linkrejected CDA Observation t2018‑04‑16 12:13:51
2.16.840.1.113883.3.1937.99.61.45.10.17linkcancelled CDA Adipositas Studie2018‑04‑24 10:41:37
2.16.840.1.113883.3.1937.99.61.45.10.37linkdraft Dok3 Sonstiges2018‑05‑02 17:52:41
2.16.840.1.113883.3.1937.99.61.45.10.39linkdraft Dok3 kleines Blutbild ?2018‑05‑02 17:58:11
2.16.840.1.113883.3.1937.99.61.45.10.50linkdraft ASIC weitere Vitaldaten2018‑05‑08 16:29:04
2.16.840.1.113883.3.1937.99.61.45.10.62Containmentdraft CDA Observation2018‑08‑28 13:22:11
2.16.840.1.113883.3.1937.777.17.10.47linkrejected BC CDA Organizer2017‑04‑02 19:50:56
2.16.840.1.113883.3.1937.777.17.10.48linkrejected BC Clinically Measured Observations Organizer2017‑04‑02 19:58:41
2.16.840.1.113883.3.1937.777.17.10.50linkdraft BC CDA Organizer2017‑04‑02 20:15:06
2.16.840.1.113883.3.1937.777.21.10.6Containmentdraft CDA Observation2018‑07‑30 14:20:18
2.16.840.1.113883.3.1937.777.24.10.22Containmentdraft Omics2019‑02‑01 16:40:46
2.16.840.1.113883.3.1937.777.24.10.51Containmentdraft CDA Procedure B2019‑04‑01 15:54:18
2.16.840.1.113883.3.1937.777.26.10.1linkdraft Konsilanfrage2018‑07‑20 11:22:22
2.16.840.1.113883.3.1937.777.29.10.1linkdraft CDA ClinicalDocument (with StructuredBody)2019‑05‑02 16:51:55
2.16.840.1.113883.3.1937.777.60.10.3linkdraft DK Resume Section2021‑08‑09 13:15:46
2.16.840.1.113883.3.1937.777.78.10.8Containmentcancelled CDA Observation2024‑01‑26 11:33:16
2.16.840.1.113883.10.12.2linkactive CDA ClinicalDocument (with StructuredBody)2005‑09‑07
2.16.840.1.113883.10.12.112linkactive CDA component2005‑09‑07
2.16.840.1.113883.10.12.201linkactive CDA Section2005‑09‑07
2.16.840.1.113883.10.12.202linkactive CDA StructuredBody2005‑09‑07
2.16.840.1.113883.10.12.300linkactive CDA Clinical Statement2005‑09‑07
2.16.840.1.113883.10.12.301linkactive CDA Act2005‑09‑07
2.16.840.1.113883.10.12.302Containmentactive CDA Encounter2005‑09‑07
2.16.840.1.113883.10.12.303Containmentactive CDA Observation2005‑09‑07
2.16.840.1.113883.10.12.304Containmentactive CDA ObservationMedia2005‑09‑07
2.16.840.1.113883.10.12.305Containmentactive CDA Organizer2005‑09‑07
2.16.840.1.113883.10.12.306Containmentactive CDA Procedure2005‑09‑07
2.16.840.1.113883.10.12.307Containmentactive CDA RegionOfInterest2005‑09‑07
2.16.840.1.113883.10.12.308Containmentactive CDA SubstanceAdministration2005‑09‑07
2.16.840.1.113883.10.12.309Containmentactive CDA Supply2005‑09‑07
2.16.840.1.113883.10.21.4.1Containmentpending UV Medication Order (STU1)2015‑10‑07
2.16.840.1.113883.10.21.4.1Containmentpending UV Medication Order (R1-STU2-ballot)2021‑08‑04 17:03:38
2.16.840.1.113883.10.21.4.1Containmentdraft UV Medication Order (2023)2023‑01‑30 08:30:30
2.16.840.1.113883.10.21.4.1Containmentdraft UV Medication Order (2023)2023‑01‑31 10:52:39
2.16.840.1.113883.10.21.4.1Containmentdraft UV Medication Order (2023)2023‑01‑31 11:29:28
2.16.840.1.113883.10.21.4.3Containmentpending UV ClinicalStatement Observation (R1-STU2-ballot)2016‑05‑01
2.999.1.1linkdraft tsc_test1_Obs1 (derived from CDA Observation)2016‑07‑01 16:24:10
2.999.2.1Containmentdraft tsc_test1_Obs2 (derived from tsc_test1_Obs1)2016‑07‑01 16:44:35
ItemDTCardConfDescriptionLabel
@typeCode
cs0 … 1FPRCN
hl7:criterion
1 … 1CDAPdotstion
@classCode
cs0 … 1FOBS
@moodCode
cs0 … 1FEVN.CRT
hl7:code
CD0 … 1CDAPdotstion
@codeSystem
CONF0 … 1F2.16.840.1.113883.5.4
hl7:text
ED0 … 1CDAPdotstion
hl7:value
ANY0 … 1CDAPdotstion